Company: Cipla Ltd. Category: Company News

Post-acquisition, AMP Solar will become an associate of Cipla Limited.
May 24, 2019, 8:24 a.m.

Check out the companies which will be in focus during trade today based on recent and latest news developments.
May 24, 2019, 8:07 a.m.

Higher competitive intensity, increasing investments, and moderate growth could weigh on returns
May 23, 2019, 12:09 a.m.

The consolidated net sales rose 22% to ₹4,271 crore.The company's board recommends a dividend of ₹3 per share
May 22, 2019, 1:55 p.m.

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Ambrisentan tablets,
April 30, 2019, 12:41 p.m.

The USFDA has classified both the recalls as a Class-II recall
April 28, 2019, 12:50 p.m.

Drug major Cipla Ltd. said its South African subsidiary will acquire 30 % stake in connected healthcare firm Brandmed Pty Ltd for an upfront cash consideration of ZAR 65 million (nearly Rs 32 crore).
April 17, 2019, 6:01 a.m.

Drug major Cipla on Tuesday said its South Africa-based subsidiary will acquire 30 per cent stake in the connected healthcare firm Brandmed (Pty) Ltd
April 16, 2019, 10:34 p.m.

Cipla and Pulmatrix inks agreement for the co-development and commercialisation of Pulmazole.As per the pact, Cipla will make an upfront payment of $22 million to Pulmatrix in exchange for assignment of all rights for Pulmazole in relation to pulmonary indications
April 15, 2019, 9:06 p.m.

In an effort to address patients with small airway respiratory diseases, drugmaker Cipla has rolled out its extra-fine particle beclomethasone-formot
April 12, 2019, 2:29 p.m.